35
Views
6
CrossRef citations to date
0
Altmetric
Research Article

A Nationwide Survey of the Management of Unintentional—Low Dose Tricyclic Antidepressant Ingestions Involving Asymptomatic Children: Implications for the Development Of an Evidence-Based Clinical Guideline

, , &
Pages 15-19 | Published online: 23 Feb 2000

REFERENCES

  • Walsh D A. Cyclic antidepressant overdose in children: A proposed treatment protocol. Ped Emerg Care 1986; 2: 28–35
  • Hayes A, Panich M L, Barker E. Imipramine dosage in children: A comment on imipramine and electrocardiographic abnormalities in hyperactive children. Am J Psychiatry 1975; 132: 545–547
  • Winsberg B, Goldstein S, Yepes L. Imipramine and electrocardiographic abnormalities in hyperactive children. Am J Psychiatry 1975; 132: 542–545
  • Biederman J. Pharmacological treatment of adolescents with affective disorders and attention deficit disorder. Psychopharmacology Bull 1988; 24: 81–87
  • Donnelly M, Zametkin A J, Rapoport J L. Treatment of childhood hyperactivity with desipramine; plasma drug concentration, cardiovascular effects, plasma and urinary catecholamine levels and clinical response. Clin Pharm Ther 1986; 39: 72–81
  • Wilens T E, Biederman J, Baldessarini R J. Electrocardiographic effects of desipramine and 2-hydroxydesipramine in children, adolescents, and adults treated with desipramine. J Am Acad Child Adol Psych 1993; 32: 798–804
  • Benowitz N L. Cyclic antidepressants. Poisoning and Drug Overdose, K Olsen. 2nd ed, Appleton and Lange, Norwalk 1993; 147–150
  • Manoguerra A S. Tricyclic antidepressants. Crit Care Quarterly 1982; 43–51
  • Ellenhorn E. Cyclic antidepressants. Ellenhorn's Medical Toxicology, E Ellenhorn. Williams, Baltimore 1997; 624–650
  • Fetner H H, Geller B. Lithium and tricyclic antidepressants. Psych Clin North Am 1992; 15: 223–224
  • Beiderman J, Baldessarini R J, Wright V, et al. A double-blind placebo controlled study of desipramine in the treatment of ADD: II. Serum drug levels and cardiovascular findings. J Am Acad Child Adoles Psychiatry 1989; 28: 903–911
  • Litovitz T L, Klein-Schwartz W, Dyer K S, Shannon M, et al. 1997 Annual report of the American Association of Poison Control Centers. Am J Emerg Med 1998; 15: 484
  • Poisoning and Toxicology Compendium, J B Leikin, F P Paloucek. Lexicomp Publishing, Cleveland, OH 1998; 130,323
  • Puig-Antich J, Perel J M, Lupatkin W, et al. Imipramine in prepubertal major depressive disorders. Arch Gen Psychiatry 1987; 44: 81–89
  • McFee R B, Caraccio T R, Mofenson H C. Pediatric considerations in the management of tricyclic antidepressants. J Toxicol Clin Toxicol 1998; 36: 519
  • Revicki D A, Palmer C S, Phillips S D. Acute medical costs of fluoxetine versus tricyclic antidepressants. A prospective multicenter study of antidepressant drug overdose. Pharmacoeconomics 1997; 11: 48–55
  • Snodgrass W. Toxicology. Casarett and Doull's Toxicology, C D Klaasen. 5th ed, McGraw Hill, New York, NY 1996; 969–986
  • Love J N, Litovitz T L, Howell J M, Clancy C. Characterization of fatal beta blocker ingestion: A review of American Association of Poison Control Centers data 1985–1995. J Toxicol Clin Toxicol 1997; 35: 353–359
  • Perrson H E. Swedish poisoning information. J Toxicol Clin Toxicol 1998; 36: 205–213

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.